Ala54Thr Fatty Acid-Binding Protein 2 (FABP2) polymorphism in recurrent depression: Associations with fatty acid concentrations and waist circumference

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Mocking, Roel J T ^a   Lok, Anja ^a   Assies, Johanna ^a   Koeter, Maarten W J ^a   Visser, Ieke ^a   Ruhé, Henricus G ^a,b   Bockting, Claudi L H ^b   Schene, Aart H ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; EICOSADIENOIC ACID; FATTY ACID; FATTY ACID BINDING PROTEIN 2; ICOSAPENTAENOIC ACID; LINOLEIC ACID; THREONINE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREVALENCE; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; ALANINE; ARACHIDONIC ACID; DEPRESSIVE DISORDER, MAJOR; EICOSANOIC ACIDS; ERYTHROCYTES; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; THREONINE; WAIST CIRCUMFERENCE;

EID: 84892389225     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082980     Document Type: Article

References (42)

1. Greden JF (2001) The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry 62 Suppl 22: 5-9. PubMed: 11599650.
2. Osby U, Brandt L, Correia N, Ekbom A, Sparén P (2001) Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 58: 844-850. doi:10.1001/archpsyc.58.9.844. PubMed: 11545667.
3. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J (2010) Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk - a review of the literature. Eur J Clin Nutr 64: 16-22. doi:10.1038/ejcn.2009.68. PubMed: 19654593.
4. Vazquez G, Duval S, Jacobs DR, Silventoinen K (2007) Comparison of Body Mass Index, Waist Circumference, and Waist/Hip Ratio in Predicting Incident Diabetes: A Meta-Analysis. Epidemiol Rev 29: 115-128. doi:10.1093/epirev/mxm008. PubMed: 17494056.
5. Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS (2011) Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: National Health and Nutrition Examination Survey 2005-2006. BMC Psychiatry 11: 130.Available online at: . doi:10.1186/1471-244X-11-130 Available online at: PubMed: 21834955
6. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB (2008) Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer Mortality: Sixteen Years of Follow-Up in US Women. Circulation 117: 1658-1667. doi:10.1161/ CIRCULATIONAHA.107.739714. PubMed: 18362231.
7. Lok A, Visscher TL, Koeter MW, Assies J, Bockting CL et al. (2010) The 'Weight' of recurrent depression: a comparison between individuals with recurrent depression and the general population and the influence of antidepressants. Psychother Psychosom 79: 386-388. doi : 10.1159/000320898. PubMed: 20829650.
8. Mozaffarian D, Wu JHY (2011) Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 58: 2047-2067. doi:10.1016/j.jacc.2011.06.063. PubMed: 22051327.
9. Piomelli D, Astarita G, Rapaka R (2007) A neuroscientist's guide to lipidomics. Nat Rev Neurosci 8: 743-754. doi:10.1038/nrn2233. PubMed: 17882252.
10. Hibbeln JR, Salem N (1995) Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 62: 1-9. PubMed: 7598049.
11. Lin PY, Huang SY, Su KP (2010) A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression. Biol Psychiatry 68: 140-147. doi:10.1016/j.biopsych.2010.03.018. PubMed: 20452573.
12. McNamara RK, Carlson SE (2006) Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 75: 329-349. doi:10.1016/j.plefa.2006.07.010. PubMed: 16949263.
13. McNamara RK, Hahn CG, Jandacek R, Rider T, Tso P et al. (2007) Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 62: 17-24. doi:10.1016/j.biopsych.2006.08.026. PubMed: 17188654.
14. Assies J, Pouwer F, Lok A, Mocking RJT, Bockting CLH et al. (2010) Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLOS ONE 5: e10635. doi:10.1371/journal.pone. 0010635. PubMed: 20498721.
15. Mocking RJ, Assies J, Lok A, Ruhé HG, Koeter MW et al. (2012) Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices. PubMed: 22446846
16. Mutch DM, Wahli W, Williamson G (2005) Nutrigenomics and nutrigenetics: the emerging faces of nutrition. FASEB J 19: 1602-1616. doi:10.1096/fj.05- 3911rev. PubMed: 16195369.
17. Hodson L, Skeaff CM, Fielding BA (2008) Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 47: 348-380. doi:10.1016/j.plipres.2008.03.003. PubMed: 18435934.
18. Mocking RJT, Assies J, Koeter MWJ, Ruhé HG, Lok A et al. (2012) Bimodal distribution of fatty acids in recurrent major depressive disorder. Biol Psychiatry 71: e3-e5. doi:10.1016/S0006-3223(12)00375-7. PubMed: 21993192.
19. Bentsen H, Solberg DK, Refsum H, Gran JM, Bøhmer T et al. (2011) Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder. Biol Psychiatry 70: 97-105. doi:10.1016/j.biopsych.2011.02.011. PubMed: 21546001.
20. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G et al. (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281-1287. doi:10.1172/JCI117778. PubMed: 7883976.
21. Agren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI (2001) Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am J Clin Nutr 73: 31-35. PubMed: 11124746.
22. Albala C, Santos JL, Cifuentes M, Villarroel AC, Lera L et al. (2004) Intestinal FABP2 A54T polymorphism: association with insulin resistance and obesity in women. Obes Res 12: 340-345. doi:10.1038/oby.2004.42. PubMed: 14981227.
23. Hegele RA (1998) A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components. Clin Biochem 31: 609-612. doi:10.1016/S0009-9120(98)00078-2. PubMed: 9876891.
24. Pratley RE, Baier L, Pan DA, Salbe AD, Storlien L et al. (2000) Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 41: 2002-2008. PubMed: 11108733.
25. Wanby P, Palmquist P, Brudin L, Carlsson M (2005) Genetic variation of the intestinal fatty acid-binding protein 2 gene in carotid atherosclerosis. Vasc Med 10: 103-108. doi:10.1191/1358863x05vm609oa. PubMed: 16013194.
26. Erkkilä AT, Lindi V, Lehto S, Pyörälä K, Laakso M et al. (2002) Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease. Nutr Metab Cardiovasc Dis 12: 53-59. PubMed: 12189904.
27. Vidgren HM, Sipiläinen RH, Heikkinen S, Laakso M, Uusitupa MI (1997) Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 27: 405-408. doi:10.1046/j.1365-2362.1997.1320679.x. PubMed: 9179548.
28. Bockting CL, Schene AH, Spinhoven P, Koeter MW, Wouters LF et al. (2005) Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial. J Consult Clin Psychol 73: 647-657. doi:10.1037/0022-006X.73.4.647. PubMed: 16173852.
29. Lok A, Mocking RJT, Ruhé HG, Visser I, Koeter MWJ et al. (2012) Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology 37: 892-902. doi:10.1016/j. psyneuen.2011.10.005. PubMed: 22094110.
30. Mocking RJ, Assies J, Bot M, Jansen EH, Pouwer F (2012) Biological effects of add-on eicosapentaenoic acid supplementation in patients with diabetes mellitus and co-morbid major depression: a randomized, double-blind, placebo-controlled study.
31. Bender R, Lange S (2001) Adjusting for multiple testing-when and how? J Clin Epidemiol 54: 343-349. doi:10.1016/S0895-4356(00)00314-0. PubMed: 11297884.
32. Pusch W, Wurmbach JH, Thiele H, Kostrzewa M (2002) MALDI-TOF mass spectrometry-based SNP genotyping. Pharmacogenomics 3: 537-548. doi:10.1517/14622416.3.4.537. PubMed: 12164776.
33. Donders AR, van der Heijden GJ, Stijnen T, Moons KG (2006) Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 59: 1087-1091. doi: 10.1016/j.jclinepi.2006.01.014.
34. Gueorguieva R (2004) Move over anova: Progress in analyzing repeated-measures data andits reflection in papers published in the archives of general psychiatry. Arch Gen Psychiatry 61: 310-317. doi:10.1001/archpsyc.61.3. 310. PubMed: 14993119.
35. Marshall A, Altman DG, Holder RL, Royston P Marshall A, Altman DG, Holder RL, Royston P (2009) Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 9: 57. 1471-2288-9-57. doi:10.1186/1471-2288-9-57. PubMed: 19638200.
36. Inoue K, Kishida K, Hirata A, Funahashi T, Shimomura I Inoue K, Kishida K, Hirata A, Funahashi T, Shimomura I (2013) Low serum eicosapentaenoic acid / arachidonic acid ratio in male subjects with visceral obesity. Nutr Metab (Lond) 10: 25. 1743-7075-10-25. doi:10.1186/1743-7075-10-25. PubMed: 23497138.
37. Savva SC, Chadjigeorgiou C, Hatzis C, Kyriakakis M, Tsimbinos G et al. (2004) Association of adipose tissue arachidonic acid content with BMI and overweight status in children from Cyprus and Crete. Br J Nutr 91: 643-649. doi:10.1079/BJN20031084. PubMed: 15035692.
38. Assies J, Lok A, Bockting CL, Weverling GJ, Lieverse R et al. (2004) Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study. Prostaglandins Leukot Essent Fatty Acids 70: 349-356. doi:10.1016/j.plefa.2003.12.009. PubMed: 15041026.
39. Mocking RJT, Ruhé HG, Assies J, Lok A, Koeter MWJ et al. (2013) Relationship between the hypothalamic-pituitary-adrenal-axis and fatty acid metabolism in recurrent depression. Psychoneuroendocrinology, 38: 1607-17. PubMed: 23465556.
40. Pishva H, Amini M, Eshraghian MR, Hosseini S, Mahboob SA (2012) Effects of EPA supplementation on plasma fatty acids composition in hypertriglyceridemic subjects with FABP2 and PPARalpha genotypes. J Diabetes Metab Disord 11: 25. 2251-6581-11-25. doi:10.1186/2251-6581-11-25.
41. de Luis D, Aller R, Izaola O, Sagrado MG, de la Fuente B et al. (2012) Effect of Fatty Acid-Binding Protein 2 Ala54Thr Genotype on Weight Loss and Cardiovascular Risk Factors After a High-Polyunsaturated Fat Diet in Obese Patients. J Investig Med 60: 1194-8. PubMed: 23072901.
42. Martinez-Lopez E, Garcia-Garcia MR, Gonzalez-Avalos JM, Maldonado-Gonzalez M, Ruiz-Madrigal B et al. (2013) Effect of Ala54Thr polymorphism of FABP2 on anthropometric and biochemical variables in response to a moderate-fat diet. Nutrition 29: 46-51. doi:10.1016/j.nut.2012.03.002. PubMed: 22817827.